In this meta-analysis, we will focus on evaluating the effects of open nephroureterectomy compared with laparoscopic nephroureterectomy on postoperative results in upper urinary tract urothelial carcinoma subjects. A systematic literature search up to January 2021 was performed, and 36 studies included 23,013 subjects with upper urinary tract urothelial carcinoma at the start of the study; of them, 8,178 were laparoscopic nephroureterectomy, and 14,835 of them were open nephroureterectomy. They were reporting relationships between the efficacy and safety of open nephroureterectomy compared with laparoscopic nephroureterectomy in the treatment of upper urinary tract urothelial carcinoma. We calculated the odds ratio (OR) or the mean difference (MD) with 95% CIs to evaluate the efficacy and safety of open nephroureterectomy compared with laparoscopic nephroureterectomy in the treatment of upper urinary tract urothelial carcinoma using the dichotomous or continuous method with a random or fixed-effect model. Laparoscopic nephroureterectomy in subjects with upper urinary tract urothelial carcinoma was significantly related to longer operation time (MD, 43.90; 95% CI, 20.91-66.90, < 0.001), shorter hospital stay (MD, -1.71; 95% CI, -2.42 to -1.00, < 0.001), lower blood loss (MD, -133.82; 95% CI, -220.92 to -46.73, = 0.003), lower transfusion need (OR, 0.56; 95% CI, 0.47-0.67, < 0.001), and lower overall complication (OR, 0.79; 95% CI, 0.70-0.90, < 0.001) compared with open nephroureterectomy. However, no significant difference was found between laparoscopic nephroureterectomy and open nephroureterectomy in subjects with upper urinary tract urothelial carcinoma in 2-5 years recurrence-free survival (OR, 0.90; 95% CI, 0.69-1.18, = 0.46), 2-5 years cancer-specific survival (OR, 0.94; 95% CI, 0.69-1.28, = 0.68), and 2-5 years overall survival (OR, 1.31; 95% CI, 0.91-1.87, = 0.15). Laparoscopic nephroureterectomy in subjects with upper urinary tract urothelial carcinoma may have a longer operation time, shorter hospital stay, and lower blood loss, transfusion need, and overall complication compared to open nephroureterectomy. Further studies are required to validate these findings.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414582 | PMC |
http://dx.doi.org/10.3389/fsurg.2021.729686 | DOI Listing |
J Endourol
January 2025
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada.
To test whether the contemporary robot-assisted nephroureterectomy (RNU) is associated with more favorable in-hospital outcomes than historical RNU, relative to the same endpoints in open NU (ONU). Within the National Inpatient Sample (2008-2019), we identified RNU and ONU patients. Multivariable logistic and Poisson regression models were fitted.
View Article and Find Full Text PDFTransl Androl Urol
December 2024
Department of Urology, Peking University First Hospital, Beijing, China.
Background: Fibroepithelial polyp (FEP) in the renal pelvis is a rare benign tumor of the urinary tract. Treatment of such diseases varies from local resection to radical nephroureterectomy, either by open or endoscopic surgery. This study aims to show our successful experience in percutaneous endoscopic resection of FEP.
View Article and Find Full Text PDFInt Urol Nephrol
November 2024
Liaoning University of Traditional Chinese Medicine, Shenyang, 110000, China.
Background: The standard of care for upper tract urothelial carcinoma (UTUC) traditionally involved open nephroureterectomy with bladder cuff excision. Despite the adoption of transabdominal laparoscopic one-stage nephroureterectomy to mitigate this, the persistently high rate of postoperative intestinal obstruction remains a clinical challenge. This study introduces an innovative approach: a single-position, completely retroperitoneal laparoscopic nephroureterectomy coupled with a 75-45-degree positional change for bladder cuff resection in the treatment of UTUC.
View Article and Find Full Text PDFCurr Opin Urol
January 2025
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
Purpose Of Review: The purpose of this review is to summarize the most recent evidence on surgical management, strategies to reduce tumor recurrence, and surveillance regimens in patients diagnosed with upper tract urothelial carcinoma (UTUC) and elected for radical treatment.
Recent Findings: Minimally invasive surgery is gaining momentum in the surgical management of UTUC. Chemoprophylaxis is still the gold standard to reduce intravesical recurrence after radical nephroureterectomy (RNU).
BMC Urol
October 2024
Department of Urology, China Medical University Hospital, China Medical university, Taichung, Taiwan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!